Pomalidomide Pomalid 4mg | Anticancerdrugs | MHP - PowerPoint PPT Presentation

About This Presentation
Title:

Pomalidomide Pomalid 4mg | Anticancerdrugs | MHP

Description:

Pomalidomide is sold under the brand name Pomalid 4mg and it belongs to anti neoplastics drugs, Pomalid 4mg is doable as orally bioavailable thalidomide derivative asssociated with numerous therapeutic activities @MHP – PowerPoint PPT presentation

Number of Views:88

less

Transcript and Presenter's Notes

Title: Pomalidomide Pomalid 4mg | Anticancerdrugs | MHP


1
Pomalidomide Pomalid 4mg Anticancerdrugs MHP
2
POMALID 4MG DEFINE
  • Pomalidomide is sold under the brand name Pomalid
    4mg and it belongs to anti neoplastics drugs 
  • Pomalid 4mg is doable as orally bioavailable
    thalidomide derivative asssociated with numerous
    therapeutic activities such as immune
    modulatory, anti-angiogenesis, anti neoplastic.
    Pomalid 4mg combination with dexamethasone will
    cause liver injury

3
POMALID 4MG CLINICAL USE
  • The primary indication of Pomalid 4mg tablet is
    used in the treatment of Multiple Myeloma
    condition. In this condition, Pomalid 4mg is used
    by combining with dexamethasone. Pomalid 4mg
    capsules are applicable in Previously the
    Patients treated with two treatment such as
    proteasome inhibitor Lenalidomide. Patients who
    are suffered with disease progression condition
    Pomalid 4mg TABLET treatment should be followed
    within 60 days in patients who are concluded the
    last treatment.

4
POMALID 4MG WORKS AS
  • Pomalid 4MG has three primary pharmacological
    activities against cancer cells. Pomalidomide
    includes in the way cancer proliferation and
    provoke the apoptosis of cancer cells.
    Pomalidomide enhance the T cell natural killer
    cells interceding immunity inhibits the
    formation of pro inflammatory cytokines from
    monocytes. Pomalidomide forbid the new cell
    formation. The binding of Pomalidomide to active
    site of targeted cell causes inhibition of
    ubiquitin ligase action.

5
ADME PROPERTIES
  • The time to high serum concentration of
    Pomalidomide is reaches between 2 to 3 hours. It
    should be administered with or without food.
    Hence No effect of food should be produced
    Volume of distribution of Pomalidomide is between
    62 138L in steady state.
  • The Pomalidomide distribution by 67 of serum
    level at after 4 hours of drug intake. human
    plasma protein by bounding range of 12 44.
    Hepatically mediated through CYP1A2, CYP3A4 is
    Pomalidomide is metabolized.

6
ADME PROPERTIES
  • Pomalidomide clearance value is 7 to 10L/hr.
    Doses are excreted via urine 73 feces 15
    respectively. Doses are excreted as an unchanged
    form via urine 2 feces 8. Pomalidomide half
    life period is 9.5 hours.

7
Pomalid 4mg
  • Brand  Pomalid
  • Ingredients  Pomalidomide
  • Strength  4mg
  • Manufactured  Natco
  • Package  21 TabletsDURING MULTIPLE MYELOMA
    MALIGNANCIES

8
Dosage Management
  • DURING MULTIPLE MYELOMA MALIGNANCIES
  • The dosage recommendation of Pomalid 4mg is 4mg
    should be administered as a single dose for 1 to
    21 days of successive 28 day cycles. Pomalid is
    combined with dexamethasone with low dose.
    Administrate Dexamethasone on day 1, 8, 15 22
    of each 28 day cycle. The prescribed dose of
    dexamethasone is 40mg should be administered the
    patient having weight about 75kg. The
    prescribed dose of dexamethasone is 20mg given
    for patients weight Greater than 75kg

9
Dosage Management
  • DOSAGE ALTERATION DURING HEMATOLOGICAL
    TOXICITIES NEUTROPENIAANC
  • lt500/mcL Pomalid treatment should be postponed
    and check the CBC weekly. ANC 500/mcL Pomalid
    therapy should be continued by 3mg/day For each
    successive drop lt500/mcL Pomalid 4mg should be
    postponed. ANC 500/mcL Continue the Pomalid
    therapy with 1mg/day.

10
Dosage Management
  • THROMBOCYTOPENIA
  • Platelets count lt25000/mcL Pomalid therapy
    should be postponed and check CBC Platelets count
    50000/mcL 3mg of Pomalid should be taken daily

11
Dosage Management
  • WITH STRONG CYP1A2
  • Pomalid combined with CYP1A2 substrates causes
    increasing the plasma concentration of
    Pomalidomide and leads to elevate the risk of
    Pomalidomide.

12
Dosage Management
  • IN RENAL DAMAGED PATIENTS
  • In severe renal impaired patients, the suggested
    dose of Pomalid is 3mg per day.

13
Dosage Management
  • IN HEPATIC IMPAIRED PATIENTS
  • The advised dose is 3mg/day in severe
    condition, the suggested dose is 2mg/day given
    for mild to moderate patients.

14
POMALID 4MG DRUG INTERACTION
  • POMALID 4MG DRUG INTERACTION
  • Pomalid 4mg concurrently used with CYP1A2 drugs
    causes increased concentration of Pomalidomide.
    Overcome this problem by reducing the dose
    of Pomalid 4mg during this combination
    therapy.POMALID 4MG CONTRAINDICATION
  • Pomalid 4mg is contraindicated to Pregnancy
    Lactation Hypersensitivity reactions produced due
    to patients are contraindicated to the component
    of Pomalid 4mg .POMALID 4MG WARNING
  • The most probable worsening condition of Pomalid
    4mg tablet is Venous arterial thromboembolism
    Embryo fetal damage

15
PRESCRIPTION
  • Millionpharma.com , a fully licensed and
    regulated pharmacy medicine, takes all
    precautions to strictly abide by the laws and
    regulations set forth in the dispensing of
    prescription medications. By placing the order
    for your prescription medicines, you acknowledge
    and accept the following terms regarding the
    purchase of any prescription medicines.  Million
    pharma.com will not dispense any prescription
    medication without a valid prescription from a
    licensed physician.  If you are ordering
    prescription medication(s), you hereby confirm
    that you will send us a scanned copy of your
    valid prescription(s) via email, fax, Whatsapp,
    or by post, and this prescription shall then be
    subject to the scrutiny of and approval by our
    qualified Pharmacists.  The drug information
    provided in the Millionpharma.com is for
    informative purposes only and this Website is not
    intended to provide diagnosis, treatment or
    medical advice. We are not liable for any adverse
    effects or harm to you as a result of your
    reliance on the information in the Website. 

16
PRESCRIPTION
  • Millionpharma.com requires either the User or
    Customer or the Caregiver to confirm he/she is
    completely aware of the indications, side
    effects, drug interactions, effects of missed
    dose or overdose of the medicines he/she orders
    from us. It is imperative to seek professional
    advice from your physician before purchasing or
    consuming any medicine fromMillionpharma.com  At
     Millionpharma.com , a Caregiver can order
    prescription medicines on your behalf.

17
FOR FURTHER INFO
  • MOBILE NO  91-9940472902
  • EMAIL millionhealthpharmaceuticals_at_gmail.com
  • WEBSITE URL  https//millionpharma.com/pomalid-4m
    g.php
Write a Comment
User Comments (0)
About PowerShow.com